FEXODEEP

This brand name is authorized in Nigeria.

Active ingredients

The drug FEXODEEP contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII RPK779R03H - ACECLOFENAC
 

Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.

 
Read more about Aceclofenac
2
UNII LAV5U5022Y - METHYL SALICYLATE
 

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

 
Read more about Methyl salicylate
3
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
 
Read more about Menthol
4
Linseed oil
UNII 84XB4DV00W - LINSEED OIL
5
UNII S07O44R1ZM - CAPSAICIN
 

Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides.

 
Read more about Capsaicin

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100654
Switch country to Nigeria in order to find specific presentations of FEXODEEP

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.